Company Encyclopedia
View More
name
AGS
688581.SH
Hangzhou AGS MedTech Co., Ltd. engages in the research, development, production, sale, and service of endoscopic surgery equipment and accessories in China. It offers hemoclips; bipolar generators, CR4500 CO2 regulation units, and UW600-II water pumps; disposable stone extraction baskets, nasal biliary drainage catheters, sphincterotomes, disposable guide wires, and stone retrieval balloons; disposable bipolar ESD knives, polypectomy snares, and disposable sclerotherapy needles; and disposable grasping forceps and disposable biopsy forceps. The company was founded in 2010 and is based in China.
932.45 B
688581.SHMarket value -Rank by Market Cap -/-

Financial Score

08/11/2025 Update
B
Health Care EquipmentIndustry
Industry Ranking20/63
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreA
    • ROE11.41%B
    • Profit Margin40.82%A
    • Gross Margin70.29%A
  • Growth ScoreB
    • Revenue YoY13.32%B
    • Net Profit YoY0.53%C
    • Total Assets YoY7.83%B
    • Net Assets YoY8.39%B
  • Cash ScoreC
    • Cash Flow Margin244.99%C
    • OCF YoY13.32%B
  • Operating ScoreD
    • Turnover0.27D
  • Debt ScoreA
    • Gearing Ratio4.17%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    AGS: Net profit in the third quarter was 50.9893 million yuan, a year-on-year decrease of 30.15%

    AGS announced that its revenue for the third quarter was 157 million yuan, a year-on-year decrease of 3.89%; net profit was 50.9893 million yuan, a year-on-year decrease of 30.15%. Revenue for the first three quarters was 459 million yuan, a year-on-year increase of 7.51%; net profit was 177 million yuan, a year-on-year decrease of 10.35%

    Zhitong·
    SH
    688581
    -1.75%
    Zhitong·
    SH
    688581
    -1.75%

    AGS: New Yuan has reduced its holdings by 0.4270%

    AGS announced that its shareholder Suzhou Yuansheng Private Fund Management Partnership - Suzhou Industrial Park Xinjian Yuan Phase II Venture Capital Enterprise originally planned to reduce its holdings by no more than 1.6227 million shares from July 25, 2025, to October 23, 2025. In fact, on July 25, it reduced its holdings by 345,800 shares through centralized bidding, accounting for 0.4270%, with a transaction price of 76 to 76.6 yuan/share, cashing out 26.4148 million yuan. The reduction plan has expired, and there are still 1.2769 million shares not reduced, with current holdings of 2.888 million shares, accounting for 3.5664%

    Zhitong·
    SH
    688581
    -1.75%
    Zhitong·
    SH
    688581
    -1.75%

    AGS: Paradise Silicon Valley completed a reduction of 2.0039%

    AGS announced that its shareholder, Paradise Silicon Valley, previously planned to reduce its holdings by no more than 1.6227 million shares from July 25, 2025, to October 23, 2025, accounting for 2.0039% of the total share capital. As of September 10, 2025, it has reduced its holdings by 809,700 shares through centralized bidding and 813,000 shares through block trading, totaling 1.6227 million shares, accounting for 2.0039%. The reduction plan has been completed, and the current shareholding is 0 shares

    Zhitong·
    SH
    688581
    -1.75%
    Zhitong·
    SH
    688581
    -1.75%

    AGS invalidated part of the restricted stock for 2023, totaling 81,832 shares

    AGS canceled 81,832 restricted shares in 2023, due to reasons including the departure of incentive targets and failure to meet personal performance assessments. This decision was approved at the Compensation and Assessment Committee meeting of the Board of Directors on August 29, 2025, with the Supervisory Board and lawyers confirming the legality and compliance of the procedures. The company stated that this cancellation will not have a material impact on its financial condition and operating results, nor will it affect the stability of the management team and the implementation of the incentive plan

    Zhitong·
    SH
    688581
    -1.75%
    Zhitong·
    SH
    688581
    -1.75%

    This week, the concentration of institutional research has increased, with 4 companies receiving research from over a hundred institutions

    This week, the concentration of institutional research increased, with 67 listed companies disclosing research records, and about 70% of the companies achieved positive returns. Haineng Technology rose over 42%, FLAC, CGWS, and HAYEUR rose over 30%, and Keystone Technology rose over 25%. MTM and AGS were researched by 183 and 180 institutions respectively, becoming the companies with the most participation in research this week

    Zhitong·
    SH
    688581
    -1.75%
    SZ
    301616
    -3.64%
    SZ
    002536
    -1.11%
    Zhitong·
    SH
    688581
    -1.75%
    SZ
    301616
    -3.64%
    SZ
    002536
    -1.11%